Articles 2022

Palamarchuk K.V., Borodina T.N., Kostenko A.V., Chesnokov Y.M., Kamyshinsky R.A., Palamarchuk N.P., Yudina E.B., Nikolskaya E.D., Yabbarov N.G., Mollaeva M.R., Bukreeva T.V. Development of Submicrocapsules Based on Co-Assembled Like-Charged Silica Nanoparticles and Detonation Nanodiamonds and Polyelectrolyte Layers // Pharmaceutics. 2022, 14(3), 575.
https://doi.org/10.3390/pharmaceutics14030575
Impact Factor 2021 - 6.525
SJR - 1.054 (Q1)
WOS, SCOPUS
Yabbarov N., Nikolskaya E., Sokol M., Mollaeva M., Chirkina M., Seregina I., Gulyaev M., Pirogov Y., Petrov R. Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe // International Journal of Molecular Sciences. 2022, 23(6), 3119.
https://doi.org/10.3390/ijms23063119
Impact Factor 2021 - 6.208
SJR - 1.455 (Q1)
WOS, SCOPUS
Mariya B. Sokol, Nikita G. Yabbarov, Mariia R. Mollaeva, Margarita V. Chirkina, Murad D. Mollaev, Artur I. Zabolotsky, Sergey L. Kuznetsov, Elena D. Nikolskaya. Alpha-fetoprotein mediated targeting of polymeric nanoparticles to treat solid tumors // Nanomedicine. 2022, V. 17, Issue 18, P.: 1217–1235.
https://doi.org/10.2217/nnm-2022-0097
Impact Factor 2021 - 6.096
SJR - 0.803 (Q1)
SCOPUS, WOS
Sokol M.B., Chirkina M.V., Yabbarov N.G., Mollaeva M.R., Podrugina T.A., Pavlova A.S., Temnov V.V., Hathout R.M., Metwally A.A., Nikolskaya E.D. Structural Optimization of Platinum Drugs to Improve the Drug-Loading and Antitumor Efficacy of PLGA Nanoparticles // Pharmaceutics. 2022; 14(11): 2333.
https://doi.org/10.3390/pharmaceutics14112333
Impact Factor 2021 - 6.525
SJR - 1.054 (Q1)
SCOPUS, WOS
N.G. Yabbarov, M.D. Mollaev, A.I. Zabolotskii, D.A. Mazalev, N.V. Gorokhovets, M.B. Sokol, M.R. Mollaeva, M.V. Fomicheva, A.B. Pshenichnikova, E.D. Nikolskaya. Obtaining and Purifying the Recombinant Domain III of Human Alpha-Fetoprotein // Applied Biochemistry and Microbiology. 2022, Vol. 58, № 8, Р. 899–908. (Russian Text © The Author(s), 2022, published in Biotekhnologiya, 2021, Vol. 37, № 4, Р. 32–42).
DOI: 10.1134/S0003683822080087
Impact Factor 2021 - 1.065
SJR - 0.255 (Q4)
SCOPUS, WOS, ВАК